Literature DB >> 31712222

PTEN in Regulating Hematopoiesis and Leukemogenesis.

Yilin Wu1, Haichuan Zhu1, Hong Wu1.   

Abstract

PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. By counteracting the PI3K/AKT/mTOR pathway, PTEN plays an essential role in regulating hematopoietic stem cells (HSCs) self-renewal, migration, lineage commitment, and differentiation. PTEN also plays important roles in suppressing leukemogenesis, especially T-cell acute lymphoblastic leukemia (T-ALL). Herein, we will review the function of PTEN in regulating hematopoiesis and leukemogenesis and discuss potential therapeutic approaches against leukemia with PTEN mutations.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31712222      PMCID: PMC7528863          DOI: 10.1101/cshperspect.a036244

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  127 in total

1.  Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.

Authors:  S T Balbach; O Makarova; B R Bonn; M Zimmermann; M Rohde; I Oschlies; W Klapper; C Rössig; B Burkhardt
Journal:  Leukemia       Date:  2015-07-28       Impact factor: 11.528

2.  Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells.

Authors:  Vionnie W C Yu; Rushdia Z Yusuf; Toshihiko Oki; Juwell Wu; Borja Saez; Xin Wang; Colleen Cook; Ninib Baryawno; Michael J Ziller; Eunjung Lee; Hongcang Gu; Alexander Meissner; Charles P Lin; Peter V Kharchenko; David T Scadden
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

3.  Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.

Authors:  M Groszer; R Erickson; D D Scripture-Adams; R Lesche; A Trumpp; J A Zack; H I Kornblum; X Liu; H Wu
Journal:  Science       Date:  2001-11-01       Impact factor: 47.728

4.  Identification of a lineage of multipotent hematopoietic progenitors.

Authors:  S J Morrison; A M Wandycz; H D Hemmati; D E Wright; I L Weissman
Journal:  Development       Date:  1997-05       Impact factor: 6.868

5.  Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients.

Authors:  Liping Yang; David Bryder; Jörgen Adolfsson; Jens Nygren; Robert Månsson; Mikael Sigvardsson; Sten Eirik W Jacobsen
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

6.  Myeloid-specific deletion of tumor suppressor PTEN augments neutrophil transendothelial migration during inflammation.

Authors:  Bara Sarraj; Steffen Massberg; Yitang Li; Anongnard Kasorn; Kulandayan Subramanian; Fabien Loison; Leslie E Silberstein; Ulrich von Andrian; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies.

Authors:  Cristina Mirantes; Maria Alba Dosil; David Hills; Jian Yang; Núria Eritja; Maria Santacana; Sònia Gatius; Felip Vilardell; Alexander Medvinsky; Xavier Matias-Guiu; Xavier Dolcet
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

8.  mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.

Authors:  Demetrios Kalaitzidis; Stephen M Sykes; Zhu Wang; Natalie Punt; Yuefeng Tang; Christine Ragu; Amit U Sinha; Steven W Lane; Amanda L Souza; Clary B Clish; Dimitrios Anastasiou; D Gary Gilliland; David T Scadden; David A Guertin; Scott A Armstrong
Journal:  Cell Stem Cell       Date:  2012-09-07       Impact factor: 24.633

9.  Single-Cell RNA-Sequencing Reveals a Continuous Spectrum of Differentiation in Hematopoietic Cells.

Authors:  Iain C Macaulay; Valentine Svensson; Charlotte Labalette; Lauren Ferreira; Fiona Hamey; Thierry Voet; Sarah A Teichmann; Ana Cvejic
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

10.  PU.1 controls fibroblast polarization and tissue fibrosis.

Authors:  Thomas Wohlfahrt; Simon Rauber; Steffen Uebe; Markus Luber; Alina Soare; Arif Ekici; Stefanie Weber; Alexandru-Emil Matei; Chih-Wei Chen; Christiane Maier; Emmanuel Karouzakis; Hans P Kiener; Elena Pachera; Clara Dees; Christian Beyer; Christoph Daniel; Kolja Gelse; Andreas E Kremer; Elisabeth Naschberger; Michael Stürzl; Falk Butter; Michael Sticherling; Susetta Finotto; Alexander Kreuter; Mark H Kaplan; Astrid Jüngel; Steffen Gay; Stephen L Nutt; David W Boykin; Gregory M K Poon; Oliver Distler; Georg Schett; Jörg H W Distler; Andreas Ramming
Journal:  Nature       Date:  2019-01-30       Impact factor: 49.962

View more
  3 in total

1.  PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway.

Authors:  Zixuan Wang; Xinyuan Wei; Caili Ji; Wenhua Yu; Chuanwang Song; Caizhi Wang
Journal:  Immun Inflamm Dis       Date:  2022-07

2.  Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.

Authors:  Haichuan Zhu; Bingjie Dong; Yingchi Zhang; Mei Wang; Jianan Rao; Bowen Cui; Yu Liu; Qian Jiang; Weitao Wang; Lu Yang; Anqi Yu; Zongru Li; Chao Liu; Leping Zhang; Xiaojun Huang; Xiaofan Zhu; Hong Wu
Journal:  Blood Sci       Date:  2022-02-04

Review 3.  Advances in molecular characterization of myeloid proliferations associated with Down syndrome.

Authors:  Jixia Li; Maggie L Kalev-Zylinska
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.